Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Liquid Biopsies Remain Wait and See for Some Clinicians
Circulating Biomarker Assays Promise to Refresh Cancer Profiling and Monitoring Practices
For full access to this article login to GEN Select now.
Keeping an Eye on Rising Biotech Firms
Roth Conference Showcases Potential Winners in the Long-Term Life Science Stock Market
- Biotechnology, drug discovery, and drug delivery were in the spotlight when Roth Capital Partners hosted its “19th Annual Stock Conference” recently. About 300 companies from diverse industry sectors made presentations during the conference. The average market cap of the presenting companies was approximately $360 million in keeping with ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.